The BioMelbourne Network is Victoria's leading industry association representing organisations across biotechnology, medical technology, and health innovation. As the peak industry body, it brings together researchers, industry leaders, government, and investors to advance one of Australia's most dynamic life sciences ecosystems.
This year, the annual BioSymposium will focus on the rapidly evolving field of biobanking, exploring how governance, regulation and emerging technologies are shaping the future of health data and biomedical research.
Victoria possesses some of Australia's most valuable health data assets, including biobanks, clinical registries and pathology datasets. However, many of these assets remain underutilised due to challenges surrounding governance, regulatory compliance and AI readiness. At the same time, Australia's regulatory landscape continues to evolve rapidly, driven by initiatives such as the Therapeutic Goods Administration's (TGA) ongoing review of software, including Artificial Intelligence, as a medical device.
The BioSymposium will examine these intersecting trends, highlighting how robust governance, quality systems, regulatory compliance, and AI readiness are essential to unlocking the value of health data while strengthening Victoria's position as an attractive destination for clinical research organisations (CROs), sponsors, biotechnology companies and emerging health technology innovators.
SeerPharma is proud to sponsor and support this important industry event. For many years, we have partnered with tissue banks and biobanking organisations throughout Australia and New Zealand, providing specialist consulting, quality management support and training across Good Manufacturing Practice (GMP), quality systems and regulatory compliance.
Our dedicated Good Manufacturing Practice (GMP) for Tissue Banks training program continues to support organisations in maintaining compliant, efficient and high-quality tissue banking operations.
The symposium will be held on Wednesday, 7 October 2026, at the Melbourne Museum, 11 Nicholson Street, Carlton, Victoria.
The program will explore several critical industry themes, including:
Biobanks and Registries – Transforming underutilised health data assets through effective governance, compliance, liability management, and strategic value creation.
Making Data Assets Work – Enabling portability, scalability, interoperability, and commercialisation while establishing sustainable and compliant operating models.
Regulatory Developments – Navigating evolving regulatory expectations, including national standards, data sovereignty, and contemporary compliance requirements.
The event has been designed for a broad cross-section of the life sciences sector, including:
Biobanking professionals
Clinical researchers, principal investigators and research institutions
Biotechnology, medical technology and digital health companies
Clinical Research Organisations (CROs) and contract service providers
Pharmaceutical and medical device manufacturers
Regulatory affairs, quality, and compliance professionals
AI, health informatics and digital transformation leaders
Click here for more information, and to register to attend this in-person event..
Supporting industry-leading events such as this reflects our ongoing commitment to advancing quality, regulatory excellence and innovation across the life sciences sector. By sharing knowledge, strengthening industry capability and fostering collaboration, we continue to pursue our mission of Advancing Quality and GMP best practice in the Asia-Pacific region.
We look forward to joining industry colleagues at this important event and hope to see you there.